CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. ...
Q2 2026
Aug 10, 2026
Q1 2026
May 4, 2026
FY 2025
Feb 12, 2026
Q4 2025
Q3 2025
Nov 10, 2025
